Zenzmaier et al. reported that DKK3 levels in seminal plasma were significantly elevated in biopsy-confirmed prostate cancer patients, because loss of expression seems to be counterbalanced by upregulation of DKK3 expression (31). This evidence concerns the gene DKK3 and prostate cancer.